L-R: Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

18 June 2024FeaturesEuropeAnna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

Life sciences cases at the UPC will surely rise, but is the court prepared?

Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

UPC bans Meril Life Sciences from selling infringing heart valve

GSK triumphs in EPO appeal, revoking Pfizer patent

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

CRISPR patents revoked following Nobel Prize winners’ withdrawal

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Life sciences cases at the UPC will surely rise, but is the court prepared?

Editor's picks

Editor's picks

More features